CIK 0001253689
- Non-accelerated filer
- Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +1 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K Reporting owner sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | Hahn Brian M. SVP Finance, CFO | Purchase | +17,500 | $0.25 | $4K | 70,643 |
| 2024-01-12 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-05-17 | Hahn Brian M. SVP Finance, CFO | Sale | −3,700 | $1.95 | $7K | 53,143 |
| 2023-01-19 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +246,300 | 246,300 | ||
| 2022-11-11 | Hahn Brian M. SVP Finance, CFO | Purchase | +20,000 | $1.06 | $21K | 56,843 |
| 2022-03-09 | Hahn Brian M. SVP Finance, CFO | Sale | −2,917 | $1.09 | $3K | 36,843 |
| 2022-01-21 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +164,700 | 164,700 | ||
| 2022-01-21 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +47,700 | 47,700 | ||
| 2021-01-20 | Hahn Brian M. SVP Finance, CFO | Grant or award | +34,500 | 39,760 | ||
| 2021-01-20 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2020-12-16 | Hahn Brian M. SVP Finance, CFO | Exercise or conversion | +5,260 | $1.12 | $6K | 5,260 |
| 2020-12-16 | Hahn Brian M. SVP Finance, CFO | Exercise or conversion · Employee Stock Option (right to buy) | −5,260 | 0 | ||
| 2020-01-22 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2019-01-17 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2018-06-11 | Hahn Brian M. CFO | Exercise or conversion | +5,260 | $1.12 | $6K | 19,345 |
| 2018-06-11 | Hahn Brian M. CFO | Sale | −19,345 | $18.04 | $349K | 0 |
| 2018-06-11 | Hahn Brian M. CFO | Exercise or conversion · Employee Stock Option (right to buy) | −5,260 | 5,260 | ||
| 2018-01-10 | Hahn Brian M. CFO | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2017-01-04 | Hahn Brian M. CFO | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2016-01-07 | Hahn Brian M. CFO | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 |
Page 1 of 2 · 24 trades